Most Recent

image: Cancers Relapse by Feeding Off Immune Signals

Cancers Relapse by Feeding Off Immune Signals

By | October 16, 2017

In mice, the tumor cells are able to thwart the immune response that would kill them—but immunotherapy prevented the return of melanoma.

0 Comments

A needle-free alternative to the finger-prick test would be a godsend for many sufferers of diabetes, but the industry has yet to clear the technological hurdles.

1 Comment

Spark Therapeutics’s Luxturna would be the first approved therapy in the U.S. that replaces or repairs a defective gene inherited from one’s parents.

1 Comment

Combined transcription and genome data from multiple tissues in hundreds of human donors reveal links between genotype and gene expression across the body.

1 Comment

image: Prizes Bigger than the Nobel

Prizes Bigger than the Nobel

By | October 5, 2017

The Nobel Prize may garner the most attention, but there are other biomedical awards at least as lucrative.

0 Comments

Chemistry Nobel goes to Jacques Dubochet, Joachim Frank, and Richard Henderson. 

1 Comment

Tissue recipients were treated as “guinea pigs,” says investigation leader.

0 Comments

Mice receiving the treatment produced their own monoclonal antibodies and survived infection with the life-threatening pathogen Pseudomonas aeruginosa.

2 Comments

image: Image of the Day: Fragile Brain

Image of the Day: Fragile Brain

By | October 3, 2017

In Fragile X syndrome—a genetic mishap that results in cognitive delays—the lack of a translation-repressing protein leads to the rampant accumulation of other proteins in the mouse brain.

0 Comments

image: Q&A with Michael Young, Nobel Laureate

Q&A with Michael Young, Nobel Laureate

By | October 2, 2017

Young talks with The Scientist about studying circadian rhythms in fruit flies, the applications of his work beyond Drosophila, and winning the prize. 

1 Comment

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. Effects of Neanderthal DNA on Modern Humans
  3. Flux and Uncertainty in the CRISPR Patent Landscape
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech